Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Small Cell Lung Carcinoma × camrelizumab × Clear all

Phase

Status

Unknown 3 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Stomach Neoplasms 6 Esophageal Neoplasms 3 Breast Neoplasms 3 Triple Negative Breast Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Recurrence 2 Neoplasm Metastasis 2 Nasopharyngeal Carcinoma 2 Lung Neoplasms 2 Esophageal Squamous Cell Carcinoma 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma, Hepatocellular 2 Biliary Tract Neoplasms 2 Advanced Gastric Cancer 2 Uterine Cervical Neoplasms 1 Thoracic Neoplasms 1 Solid Tumor 1 Small Cell Lung Carcinoma 1 Respiratory Tract Neoplasms 1 Respiratory Tract Diseases 1 Neoplasms by Site 1 Mouth Neoplasms 1 Lung Diseases 1 Liver Diseases 1 Hodgkin Disease 1 Hematologic Neoplasms 1 Gestational Trophoblastic Disease 1 Gastrointestinal Neoplasms 1 Esophageal Diseases 1 Drug-Related Side Effects and Adverse Reactions 1

Interventions

Carboplatin 45 Etoposide 42 Cisplatin 40 Topotecan 36 Irinotecan 20 Paclitaxel 15 Gemcitabine 13 Nivolumab 12 pembrolizumab 11 Ipilimumab 10 atezolizumab 9 durvalumab 8 Radiotherapy 8 Bevacizumab 7 rovalpituzumab tesirine 6 amrubicin 6 Doxorubicin 6 Docetaxel 6 Counseling 6 trilaciclib 5 Sunitinib 5 Psychiatric Rehabilitation 5 Platinum 5 Imatinib Mesylate 5 Bortezomib 5 tremelimumab 4 olaparib 4 etoposide phosphate 4 PM 01183 4 Early Intervention, Educational 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03417895 2024-08-07

PASSION

Jiangsu HengRui Medicine Co., Ltd.

Phase 2 Completed

59 enrolled 17 charts

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡